z-logo
Premium
Treating hepatitis B virus/hepatitis C virus coinfected patients with direct‐acting hepatitis C virus antivirals only is not safe
Author(s) -
Ozaras Resat,
Sunbul Mustafa,
Parlak Mehmet,
Bodur Hurrem,
Leblebicioglu Hakan
Publication year - 2016
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.28592
Subject(s) - medicine , virology , hbsag , entecavir , sofosbuvir , simeprevir , hepatitis b virus , daclatasvir , lamivudine , gastroenterology , hepatitis c virus , ribavirin , virus

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom